FILTER
FILTERED INTERVIEW RESULTS
Omar Farouk Ibrahim
SECRETARY GENERAL, AFRICAN PETROLEUM PRODUCERS' ORGANIZATION (APPO)
"By developing intra-African energy infrastructure, we can reduce costs, improve energy access, and encourage local refining and petrochemical industries."
Omar Farouk Ibrahim
SECRETARY GENERAL, AFRICAN PETROLEUM PRODUCERS' ORGANIZATION (APPO)
"To us, energy poverty poses a more immediate existential challenge than climate change."
Stephen G. Roman
PRESIDENT AND CEO, GLOBAL ATOMIC
"Dasa is the largest and highest-grade uranium deposit under development in Africa. We are excited to have started the underground development and look forward to transitioning from explorer to developer to a new uranium producer."
Stephen G. Roman
PRESIDENT AND CEO, GLOBAL ATOMIC
Global Atomic explains progress at its Dasa uranium project in Niger.
Simon Meadows Smith
MANAGING DIRECTOR, SEMS EXPLORATION
"Across the region, the old model of flying in expats to do the technical job combined with a few locals doing the rest of the work on the ground has to change and has started to change."
Shahram Tafazoli
FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Liam Morrissey
CEO, MS RISK
MS Risk speaks of the danger that the war in the Sahel represents to mines and businesses.
Stephen G. Roman
PRESIDENT & CEO, GLOBAL ATOMIC CORP.
Global Atomic Corp explains development at its Deva project in Niger.
Joel Cavaille & Samuel Modicom
CEO, JA DELMAS & COUNTRY MANAGER, SAUDEQUIP
Saudequip supplies the Caterpillar brand across francophone West Africa and is benefitting from the region’s current boom in mining.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
